Novo Nordisk A/S is asking for more time to answer questions from US Senator Bernie Sanders on the prices of Ozempic and ...
Sen. Bernie Sanders, chair of the Senate Health, Education, Labor and Pensions Committee, has demanded to know why Americans ...
Eli Lilly has made inroads in the red-hot weight-loss market thanks to its diabetes blockbuster, Mounjaro.
Goldman Sachs said Amgen's experimental GLP-1 drug could have peak sales of $5 billion, or 5% of the estimated $100 billion weight loss drug market.
Citing a recent study by Yale University, which suggests it costs just $5 (£4) to produce a month's supply of Wegovy and Ozempic ... suggesting the product could become commercially available ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips There are no true “under-the-radar stocks” in the ...
TV networks will be asked for 'rollbacks' on pricing for ad deals in the 2024 upfront, a sign of decreased leverage in the ...
Citing a recent study by Yale University, which suggests it costs just $5 (£4) to produce a month's supply of Wegovy and ...
The Dow Jones Industrial Average and other major stock indexes ended the week on a high note thanks to renewed hope for ...
How legitimate are claims by some content creators that the average person can earn passive income from social media ...
The healthcare real estate investment trust, whose portfolio includes almost 700 properties, said it would contribute 12 of them valued at $382.5 million to the joint venture and more could be added.
Ozempic has helped countless consumers across the country lose weight and keep it off. However, women taking the drug are now ...